Abstract: The present invention relates to a pharmaceutical composition comprising at least one mRNA comprising at least one coding region for at least one antigen from a tumour, in combination with an aqueous solvent and preferably a cytokine, e.g. GM-CSF, and a process for the preparation of the pharmaceutical composition. The pharmaceutical composition according to the invention is used in particular for therapy and/or prophylaxis against cancer.
Type:
Grant
Filed:
June 18, 2004
Date of Patent:
July 10, 2012
Assignee:
CUREVAC GmbH
Inventors:
Ingmar Hoerr, Florian Von Der Mulbe, Steve Pascolo